抗结核治疗中预防应用保肝药临床试验的中文文献系统评价
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi(2010)
Abstract
我国结核病负担较高,每年仅新发现的初复治病例即达98万[1],加上原患未治愈者,每年接受治疗的病例超过100万.抗结核治疗使用的一、二线药物均可引起不良反应,其中影响最大且发病率较高的为肝损害[2].
MoreTranslated text
Key words
Anti-tubercular agents,Hepatitis,druginduced,Clinical trials,Hepatoprotector
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined